|
Copyright Page |
5 |
|
|
DEDICATION |
6 |
|
|
PREFACE |
7 |
|
|
ABOUT THE EDITORS... |
8 |
|
|
ABOUT THE EDITORS... |
9 |
|
|
PARTICIPANTS |
10 |
|
|
Table of Contents |
15 |
|
|
ACKNOWLEDGEMENTS |
21 |
|
|
Chapter 1 An Overview of SphingolipidMetabolism:From Synthesis to Breakdown |
22 |
|
|
Sphingolipid Properties in Membranes |
23 |
|
|
De Novo Synthesis in the ER |
24 |
|
|
Serine Palmitoyltransferase and 3-Ketodihydrosphingosine Reductase |
25 |
|
|
Dihydroceramide Synthases/Ceramide Synthases and Dihydroceramide Desaturase |
26 |
|
|
Ceramide Transport from the ER to the Golgi |
27 |
|
|
Synthesis of Complex Sphingolipids |
28 |
|
|
Ceramide Galactosyltransferase and Galactosphingolipids |
28 |
|
|
Glucosylceramide Synthase and Derivatives of Glucosylceramide |
29 |
|
|
Sphingomyelin Synthesis |
29 |
|
|
Ceramide Kinase and Ceramide-1-Phosphate |
30 |
|
|
Catabolizing Complex Sphingolipids and Sphingomyelins into Ceramide |
31 |
|
|
The Catabolism of Ceramides and the Final Common Breakdown Pathway |
33 |
|
|
Acid, Neutral and Alkaline Ceramidases |
33 |
|
|
Sphingosine-1-Phosphate and Sphingosine Kinases 1 and 2 |
35 |
|
|
Lipid Phosphate Phosphatases, S1P Phosphatases and the Salvage Pathway |
36 |
|
|
S1P Lyase in the Removal of Sphingoid Bases |
37 |
|
|
Conclusion |
38 |
|
|
References |
38 |
|
|
Chapter 2 Sphingolipid Transport |
45 |
|
|
Introduction |
45 |
|
|
Intramembrane Sphingolipid Movements |
46 |
|
|
Lateral Diffusion and Lateral Phase Separation of Sphingolipids |
46 |
|
|
Sphingolipid Raft Dynamics |
47 |
|
|
Transbilayer Transport |
48 |
|
|
Transbilayer Transfer of Sphingomyelin and Complex Glycosphingolipids |
49 |
|
|
Transbilayer Transfer of Monohexosylsphingolipids |
52 |
|
|
Transbilayer Transfer of Ceramide and Sphingoid Bases |
52 |
|
|
Transbilayer Transfer of Sphingosine-1-Phosphate |
53 |
|
|
Intermembrane Sphingolipid Transport |
53 |
|
|
Protein-Mediated Sphingolipid Transport |
54 |
|
|
CERT-Mediated Transport of Ceramides |
54 |
|
|
FAPP2-Mediated Transport of Glucosylceramide |
57 |
|
|
Glycolipid Transfer Proteins |
57 |
|
|
Membrane Contacts |
58 |
|
|
Sphingolipid Vesicular Transport |
58 |
|
|
Biosynthetic Vesicular Pathway |
58 |
|
|
Endocytic Pathway |
59 |
|
|
Conclusion |
60 |
|
|
References |
61 |
|
|
Chapter 3 Sphingolipid Analysisby High Performance LiquidChromatography-Tandem MassSpectrometry (HPLC-MS/MS) |
67 |
|
|
Introduction |
67 |
|
|
Sphingolipids: Structure and Composition |
68 |
|
|
LC-MS Methods for Detection and Analysis of Bioactive Sphingolipids |
70 |
|
|
Lipidomic Approach |
70 |
|
|
Sample Preparation |
70 |
|
|
Analysis of Intact Sphingolipids by Mass Spectrometry |
71 |
|
|
Mechanism of Electrospray Ionization Mass Spectrometry (ESI/MS) |
72 |
|
|
MS Scan Modes |
72 |
|
|
Specific Scan Modes for MS/MS Instrumentation |
73 |
|
|
Product Ion Scan |
73 |
|
|
Neutral Loss (NL) |
73 |
|
|
Precursor Ion Scan (PI) |
73 |
|
|
Multiple Reaction Monitoring (MRM) |
73 |
|
|
Sphingolipid Identification |
73 |
|
|
HPLC-MS/MS Methodology |
74 |
|
|
Quantitation |
75 |
|
|
Selection of Internal Standards (ISs) |
76 |
|
|
Quantitative Calibration |
76 |
|
|
Data Handling |
76 |
|
|
Alternative Methodology |
77 |
|
|
Conclusion |
77 |
|
|
References |
77 |
|
|
Chapter 4 Ceramide Synthases:Roles in Cell Physiology and Signaling |
81 |
|
|
Introduction |
81 |
|
|
Fatty Acid Specificity, Kinetics and Tissue Distribution |
83 |
|
|
Inhibitors |
84 |
|
|
Fumonisins |
84 |
|
|
Australifungin |
85 |
|
|
FTY720 |
85 |
|
|
Posttranslational Modifications |
85 |
|
|
Membrane Topology |
85 |
|
|
Why Are There So Many Mammalian CerS? |
87 |
|
|
Roles of CerS in Signal Transduction and Disease |
88 |
|
|
Conclusion |
89 |
|
|
References |
89 |
|
|
Chapter 5 Tales and Mysteries of the EnigmaticSphingomyelin Synthase Family |
93 |
|
|
Sphingomyelin Biosynthesis: An Historical Perspective |
93 |
|
|
Initial Milestones |
93 |
|
|
Localization of SM Synthase Activity in Cells |
94 |
|
|
Discovery of a Ceramide Transfer Protein with a Key Role in SM Biosynthesis |
96 |
|
|
Alternative Pathways of SM Biosynthesis and Analogous Reactions |
96 |
|
|
Physicochemical Properties of SM |
97 |
|
|
The Multigenic Sphingomyelin Synthase (SMS) Family |
97 |
|
|
SMS Cloning Strategies |
97 |
|
|
Structural Organization and Reaction Chemistry of SMS Family Members |
98 |
|
|
SMS Family Members Display Striking Variations in Substrate Specificity |
99 |
|
|
Differential Expression of SMS1 and SMS2 |
100 |
|
|
Cellular Functions of SMS Family Members |
100 |
|
|
SMS1 and SMS2 as Regulators of SM Homeostasis and Receptor-Mediated Signaling |
100 |
|
|
SMS1 and SMS2 as Regulators of Lipid-Based Signaling |
101 |
|
|
Conclusion |
102 |
|
|
References |
103 |
|
|
Chapter 6 Ceramide in Stress Response |
107 |
|
|
Introduction |
107 |
|
|
Chemical Structure and Biophysical Properties of Ceramide |
108 |
|
|
Changes in Ceramide Mass during Stress |
108 |
|
|
Mechanisms for Ceramide Generation during Stress |
112 |
|
|
Role of the De Novo Pathway for Ceramide Generation in Cellular Stress Response |
112 |
|
|
Heat Stress |
113 |
|
|
Septic Shock |
113 |
|
|
Lipotoxicity and Insulin Desensitization |
114 |
|
|
Programmed Cell Death |
114 |
|
|
Autophagy |
115 |
|
|
Mechanisms of Activation of De Novo Synthesis of Ceramide during Stress |
115 |
|
|
Role of the Sphingomyelinases in Cellular Stress Response |
115 |
|
|
Neutral Sphingomyelinase |
116 |
|
|
Hepatic Acute Phase Response |
116 |
|
|
Vascular Inflammation |
116 |
|
|
Apoptosis |
116 |
|
|
Growth Arrest |
116 |
|
|
Aging and Cancer |
117 |
|
|
Mechanisms of Activation of NSMase |
117 |
|
|
Acid Sphingomyelinase |
118 |
|
|
Endotoxic Shock |
118 |
|
|
Apoptosis (reviewed in ref. 162) |
118 |
|
|
Viral and Bacterial Infections |
118 |
|
|
Mechanisms of Activation of ASMase |
118 |
|
|
Evidence for a Coordinated Regulation of Multiple Pathways for Ceramide Generation |
118 |
|
|
Mechanisms of Ceramide Effects on Cellular Functions |
119 |
|
|
Ceramide-Interacting Molecules |
119 |
|
|
PKC (reviewed in ref. 114) |
119 |
|
|
PP2A (reviewed in ref. 181) |
119 |
|
|
Cathepsin D |
119 |
|
|
Indirect Targets of Ceramide |
120 |
|
|
Modulators of Apoptosis (reviewed in ref. 184) |
120 |
|
|
Regulators of Cell Cycle |
120 |
|
|
Regulators of Inflammation |
120 |
|
|
Ceramide Effects on Membrane Organization |
121 |
|
|
Conclusion |
121 |
|
|
References |
122 |
|
|
Chapter 7 Animal Models for Studyingthe Pathophysiology of Ceramide |
130 |
|
|
Introduction |
130 |
|
|
Sphingosine Kinase 1/2 |
130 |
|
|
Ceramidases |
131 |
|
|
Acid Ceramidase |
131 |
|
|
Neutral Ceramidase |
132 |
|
|
Sphingomyelinases (SMase) and Sphingomyelin Synthases (SMS) |
132 |
|
|
Acid Sphingomyelinase (ASMase) |
132 |
|
|
Neutral Sphingomyelinase (nSMase) 1/2 |
133 |
|
|
Sphingomyelin Synthases (SMS) |
133 |
|
|
S1P Lyase |
133 |
|
|
The Other GEM for Sphingolipid-Related Enzymes |
134 |
|
|
Conclusion |
134 |
|
|
References |
135 |
|
|
Chapter 8 Ceramide-1-Phosphate in Cell Survivaland Inflammatory Signaling |
139 |
|
|
Introduction |
139 |
|
|
Ceramide-1-Phosphate Synthesis and Degradation |
140 |
|
|
Ceramide-1-Phosphate: A Key Regulator of Cell Growth and Survival |
142 |
|
|
Ceramide-1-Phosphate and the Control of Inflammatory Responses |
144 |
|
|
Ceramide-1-Phosphate Mediates Macrophage Migration |
145 |
|
|
Conclusion |
146 |
|
|
References |
147 |
|
|
Chapter 9 Ceramide-1-Phosphate in Phagocytosisand Calcium Homeostasis |
152 |
|
|
Ceramide-1-Phosphate in Phagocytosis |
152 |
|
|
Ceramide-1-Phosphate as a Regulator of Calcium Homeostasis |
155 |
|
|
Conclusion |
158 |
|
|
References |
159 |
|
|
Chapter 10 Extracellular and Intracellular Actionsof Sphingosine-1-Phosphate |
162 |
|
|
Introduction |
162 |
|
|
Sphingolipid Metabolism |
162 |
|
|
Sphingosine Kinases |
163 |
|
|
SphK1 |
164 |
|
|
SphK2 |
164 |
|
|
SphK1 vs. SphK2 |
164 |
|
|
S1P Receptors |
166 |
|
|
S1P1 |
166 |
|
|
S1P2 |
167 |
|
|
S1P3 |
167 |
|
|
S1P4 and S1P5 |
167 |
|
|
Evidence for Intracellular Targets of S1P |
168 |
|
|
S1P in Saccharomyces cerevisiae |
168 |
|
|
S1P in Arabidopsis thaliana |
168 |
|
|
S1P in Mammalian Cells |
169 |
|
|
Implications, Future Directions, and Conclusion |
171 |
|
|
References |
171 |
|
|
Chapter 11 Glucosylceramide in Humans |
177 |
|
|
Introduction |
177 |
|
|
Glucosylceramide Synthesis and Degradation |
177 |
|
|
Multiple Functions of Glucosylceramide |
179 |
|
|
Template for Higher Order Glycosphingolipids |
179 |
|
|
Membrane and Lipid Raft Constituent |
179 |
|
|
Cellular Protection in the Skin |
180 |
|
|
Cellular Protection in the Cardiovasculature |
180 |
|
|
Cellular Protection in the Brain |
181 |
|
|
Cellular Protection in the Immune System |
181 |
|
|
Cellular Protection in Carcinomas |
182 |
|
|
Conclusion |
182 |
|
|
References |
183 |
|
|
Chapter 12 Gangliosides as Regulators of CellMembrane Organization and Functions |
186 |
|
|
Introduction |
186 |
|
|
Segregation of Membrane Lipids and Detergent-Resistant Membrane Domains |
190 |
|
|
Lipid Membrane Domain Functions |
192 |
|
|
Gangliosides and Lipid Membrane Domains in the Nervous System |
192 |
|
|
The Glycosynapse |
193 |
|
|
GM3 and EGF Receptor |
194 |
|
|
GM3, Caveolae and the Regulation of Insulin Receptor and PDGF Receptor |
195 |
|
|
The Regulation of Glycosphingolipid Composition of the Plasma Membranes |
195 |
|
|
Conclusion |
197 |
|
|
References |
197 |
|
|
Chapter 13 Cancer Treatment Strategies TargetingSphingolipid Metabolism |
206 |
|
|
Introduction |
206 |
|
|
Sphingolipid Metabolism |
207 |
|
|
Ceramide Generated via Different Biochemical Routes Can Induce Apoptosis |
208 |
|
|
Ceramide as a Mediator of Cell Death by Chemopreventive Agents |
209 |
|
|
Ceramide Influences Both the Intrinsic and Extrinsic Apoptotic Pathways |
209 |
|
|
Sphingosine-1-Phosphate as a Counterbalance to Ceramide |
210 |
|
|
Inhibitory Effects of S1P on Apoptotic Pathways |
211 |
|
|
Sphingolipids Regulate Key Signaling Pathways That Control Cell Fate |
211 |
|
|
Sphingolipids and Autophagy |
213 |
|
|
Other Signaling Pathways Influenced by Sphingolipids |
214 |
|
|
Ceramide Regulates Cell Cycle Progression |
214 |
|
|
Ceramide and Telomerases |
215 |
|
|
Ceramide and S1P in Cancer Stem Cells |
215 |
|
|
Effects of S1P on Migration and Metastasis |
215 |
|
|
Cancer Cells Exhibit Molecular and Genetic Changes in Sphingolipid Metabolism |
215 |
|
|
Targeting Sphingolipids for Cancer Therapy |
217 |
|
|
S1P Signaling to Protect Normal Tissues from Therapy-Related Cytotoxicity |
219 |
|
|
Conclusion |
219 |
|
|
References |
219 |
|
|
Chapter 14 Therapeutic Strategies for Diabetesand Complications:A Role for Sphingolipids? |
227 |
|
|
Diabetes and Insulin Resistance |
227 |
|
|
Insulin Resistance and Altered Sphingolipid Metabolism |
228 |
|
|
Diabetic Pancreatic Dysfunction and Sphingolipids |
230 |
|
|
Diabetic Cardiovascular Dysfunction and Sphingolipids |
230 |
|
|
Diabetic Nephropathy and Sphingolipids |
231 |
|
|
Diabetic Retinopathy and Sphingolipids |
231 |
|
|
Therapeutics That Target Sphingolipid Metabolism or Sphingolipid Signaling in Diabetes |
232 |
|
|
Conclusion |
233 |
|
|
References |
234 |
|
|
Chapter 15 Roles for Sphingolipidsin Saccharomyces cerevisiae |
238 |
|
|
Introduction |
238 |
|
|
Sphingolipid Metabolism in S. cerevisiae |
238 |
|
|
Membrane-Associated Functions and Processes |
240 |
|
|
Signal Transduction Pathways That Require Sphingolipids |
243 |
|
|
Longevity and Cellular Aging |
245 |
|
|
Regulation of Sphingolipid Biosynthesis |
246 |
|
|
Conclusion and Future Developments |
247 |
|
|
References |
248 |
|
|
Chapter 16 Sphingolipid Signaling in FungalPathogens |
253 |
|
|
Sphingolipid Synthesis |
253 |
|
|
Cryptococcus Neofomans: Model of Sphingolipid Signaling in Fungi |
254 |
|
|
Sphingolipid Signaling in Other Pathogenic Fungi |
256 |
|
|
Conclusion |
256 |
|
|
References |
257 |
|
|
Chapter 17 Sphingolipids in Parasitic Protozoa |
259 |
|
|
Introduction |
259 |
|
|
Leishmania |
259 |
|
|
SL Pathway Genetics |
261 |
|
|
SL Salvage by Amastigotes |
261 |
|
|
Inhibition of SL Synthetic Pathways |
262 |
|
|
Trypanosoma brucei (ssp) and Trypanosoma cruzi |
262 |
|
|
Trypanosoma brucei |
262 |
|
|
Trypanosoma cruzi |
263 |
|
|
Trypanosomatid Sphingolipid Synthases |
264 |
|
|
Plasmodium falciparum |
265 |
|
|
Toxoplasma gondii |
265 |
|
|
Trichomonas vaginalis and Giardia lamblia |
266 |
|
|
Conclusion |
266 |
|
|
References |
267 |
|
|
Chapter 18 Biosynthesis of Sphingolipids in Plants(and Some of Their Functions) |
270 |
|
|
Introduction |
270 |
|
|
Pathway of Plant Sphingolipid Biosynthesis |
271 |
|
|
Functional Characterization of Genes and Enzymes Involved in Plant Sphingolipid Biosynthesis (2004-2008) |
276 |
|
|
Serine Palmitoyltransferases |
276 |
|
|
Long-Chain Base C4-Hydroxylases |
277 |
|
|
Ceramidase |
277 |
|
|
Fatty Acyl a-Hydroxylase |
277 |
|
|
Sphingolipid- 4(E)-Desaturase |
278 |
|
|
Sphingolipid- 8(E/Z)-Desaturases |
278 |
|
|
Inositolphosphorylceramide Synthase (IPCS) |
278 |
|
|
Long-Chain Base Kinase and Long-Chain Base Phosphate Phosphatase |
279 |
|
|
Long-Chain Base Phosphate Lyase |
281 |
|
|
Conclusion |
281 |
|
|
References |
282 |
|
|
Chapter 19 Computational Analysis of SphingolipidPathway Systems |
285 |
|
|
Introduction |
285 |
|
|
Sphingolipid Models and Their Potential Uses |
289 |
|
|
Conclusion |
294 |
|
|
References |
295 |
|
|
Appendix Introduction to Tools and Techniquesfor Ceramide-Centered Research |
297 |
|
|
Lipid Extraction |
297 |
|
|
Identification and Quantification of Steady State Levels of Ceramide |
297 |
|
|
Analysis of Ceramide Metabolism |
299 |
|
|
The Use of Ceramide Analogues |
300 |
|
|
Short-Chain Ceramides |
300 |
|
|
Fluorescent Ceramide Analogues |
300 |
|
|
Pharmacological Tools |
300 |
|
|
Genetic Tools |
300 |
|
|
RNA Interference |
300 |
|
|
Knockout Mice |
300 |
|
|
Conclusion |
303 |
|
|
References |
303 |
|
|
Index |
307 |
|